USP’s resources and tools to protect the supply chain of SF COVID-19 health products

Fight The Fakes’ member U.S. Pharmacopeia (USP) has recently published a suite of resources and tools to detect substandard and falsified COVID-19 treatments. The supply and demand imbalances caused by the COVID-19 pandemic has created a surge in substandard and falsified treatments and these resources aim to assist manufacturers, regulators, and quality control laboratories in helping Read more…

Update on COVID-19 linked substandard and falsified medical products from IDDO – January & February issues

The Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine and the University of Oxford have released their latest Medical Product Quality Report – COVID-19 issues, with results from February 2021. In this issue, 55 new alerts on COVID-19 products were reported on the Medicines Read more…

Update on COVID-19 linked substandard and falsified medical products from IDDO – December 2020

The latest ‘Medical Product Quality Report – COVID-19 Issues’ from Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine and the University of Oxford from December 2020 highlights the rise of substandard and falsified medicines linked to COVID-19. Throughout 2020 the MQM Globe database tracked and identified over Read more…

FIP & WHO Pharmacy Curriculum Guide on Substandard and Falsified Medicines

New Curriculum Guide and Competency Framework A curriculum guide to support educators in ensuring that pharmacists are better able to prevent substandard or falsified (SF) medicines and medical products from reaching patients has been published by the International Pharmaceutical Federation (FIP) in partnership with the World Health Organization (WHO). In Read more…